Valo Therapeutics Appoints Experienced Life Sciences Executive Anthony Giovinazzo to Board
/PRNewswire/ -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced...
Source: prnewswire.com